Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Voyager Therapeutics (VYGR) Prepaid Assets (2016 - 2025)

Voyager Therapeutics' Prepaid Assets history spans 11 years, with the latest figure at $4.3 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 45.53% year-over-year to $4.3 million; the TTM value through Dec 2025 reached $4.3 million, down 45.53%, while the annual FY2025 figure was $4.3 million, 45.53% down from the prior year.
  • Prepaid Assets for Q4 2025 was $4.3 million at Voyager Therapeutics, down from $6.6 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $10.1 million in Q1 2021 and bottomed at $3.4 million in Q2 2022.
  • The 5-year median for Prepaid Assets is $5.5 million (2023), against an average of $5.8 million.
  • The largest annual shift saw Prepaid Assets skyrocketed 91.52% in 2021 before it crashed 64.16% in 2022.
  • A 5-year view of Prepaid Assets shows it stood at $3.4 million in 2021, then rose by 23.52% to $4.2 million in 2022, then increased by 25.63% to $5.3 million in 2023, then skyrocketed by 49.4% to $7.9 million in 2024, then tumbled by 45.53% to $4.3 million in 2025.
  • Per Business Quant, the three most recent readings for VYGR's Prepaid Assets are $4.3 million (Q4 2025), $6.6 million (Q3 2025), and $9.8 million (Q2 2025).